Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BMS pulls the plug on Phase 3 trials of IDO1 inhibitor

pharmafileMay 03, 2018

Tag: BMS , cancer , IDO1 inhibitor

PharmaSources Customer Service